Two ways to reduce pain during a baby's eye exam
Part of Eyes & vision, Genetic & congenital, Pain, Women’s health & pregnancy clinical trials.
This study tests two drug-free methods to help reduce pain when premature babies get a special eye exam for retinopathy of prematurity. It may help your baby feel more comfortable during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 34 weeks of pregnancy.
- Your baby's birth weight was 5.5 pounds (2500 grams) or less.
- Your baby had no painful procedures in the hour before the eye exam.
- Your baby was fed at least one hour before the exam.
- You have given permission for your baby to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
This study tests a new way to give a nasal spray of fentanyl (a strong painkiller) to premature babies before their routine eye exams for ROP. It aims to see if this medicine reduces pain and discomfort during the exam better than current standard care.
This study tests a new educational program to help parents of premature babies understand the eye condition ROP (retinopathy of prematurity) and why screening is important. By taking part, you'll learn how to care for your baby's eye health and potentially prevent vision problems.
This study looks at the tiny blood vessels in the back of the eye (retina) of premature infants who are at risk for retinopathy of prematurity, a condition that can harm vision. It aims to improve care and monitoring by using advanced eye imaging to see more detail than current methods.
This study looks at the long-term eye health of people who were born prematurely and screened for a condition called retinopathy of prematurity (ROP), which affects the blood vessels in the eye. It aims to understand how their vision has developed over time.
This trial tests whether a low dose of conbercept, given as an eye injection, can safely treat type 1 ROP (an eye disease in premature babies). The goal is to stop abnormal blood vessel growth and prevent vision loss.
Hear when a new Retinopathy of Prematurity (ROP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.